PHK
RCKT icon

Point72 Hong Kong’s Rocket Pharmaceuticals RCKT Stock Holding History

Point72 Hong Kong’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,276
Closed -$100K – 1377
2022
Q3 		$100K Buy
+6,276
New +$97.9K 0.01% 1234
2022
Q2 		– Sell
-4,408
Closed -$70K – 2340
2022
Q1 		$70K Buy
4,408
+391
+10% +$6.75K 0.01% 1251
2021
Q4 		$88K Sell
4,017
-2,613
-39% -$71.3K 0.01% 1202
2021
Q3 		$198K Buy
+6,630
New +$241K 0.02% 1171
2020
Q3 		– Sell
-1,120
Closed -$23K – 1472
2020
Q2 		$23K Buy
+1,120
New +$20.2K ﹤0.01% 870
2020
Q1 		– Sell
-847
Closed -$19K – 1283
2019
Q4 		$19K Buy
+847
New +$14.1K 0.01% 900

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return